SEC ORDERS A SUSPENSION OF TRADING IN THE STOCK OF AURORA MEDICAL
TECHNOLOGY, INC.
The Commission today announced the temporary suspension, pursuant to
Section 12(k) of the Securities Exchange Act of 1934 (Exchange Act),
of trading in the securities of Aurora Medical Technology, Inc. (stock
symbol AROR) at 9:30 a.m. EDT, on July 14, 2006, through 11:59 p.m.
EDT, on July 27, 2006.
The Commission temporarily suspended trading in the securities of
Aurora Medical Technology, Inc. because of possible manipulative
conduct occurring in the market for the company's stock.
The Commission cautions brokers, dealers, shareholders, and
prospective purchasers that they should carefully consider the
foregoing information along with all other currently available
information and any information subsequently issued by the company.
Further, brokers and dealers should be alert to the fact that,
pursuant to Rule 15c2-11 under the Exchange Act, at the termination of
the trading suspension, no quotation may be entered unless and until
they have strictly complied with all of the provisions of the rule. If
any broker or dealer has any questions as to whether or not it has
complied with the rule, it should not enter any quotation but
immediately contact the staff of the Securities and Exchange
Commission in Washington, D.C. If any broker or dealer is uncertain as
to what is required by Rule 15c2-11, it should refrain from entering
quotations relating to Aurora Medical Technology, Inc.'s securities
until such time as it has familiarized itself with the rule and is
certain that all of its provisions have been met. If any broker or
dealer enters any quotation that is in violation of the rule, the
Commission will consider the need for prompt enforcement action. For
questions related to the operation of Rule 15c2-11, please contact the
Division of Market Regulation, Office of Interpretation and Guidance,
at (202) 551-5760.
Any broker, dealer or other person with information relating to this
matter is invited to call Gerald A. Gross, Assistant Regional
Director, in the Northeast Regional Office of the Securities and
Exchange Commission, at (212) 336-0085 or grossg@sec.gov. (Rel. 34-
54144) |
